Inter-laboratory Quality Assurance for Neonatal G6PD Screening
(Survey No: 93-03)


   Sample sent on : March 9, 2004   Report deadline : March 17, 2004

   Total screening unit11      Total reports returned11


Sample No.

A1

A2

A3

 B1

 B2

C1

C2

C3

C4

C5

D1

G6PD activity*

1

50.5

2.9

4.2()

2.4

1.98(+)

2.87(+)

2.9

5.1

2

7.5()

0.4()

0.9()

0.2(+)

0.66(+)

0.48(+)

0.6()

2.1()

3

73.5

6.9

13.3

5.9

3.97(+)

5.30

6.3

11.6

4

109.6

6.9

13.1

5.6

3.97(+)

5.70

6.1

11.6

5

50.3

3.0

3.6()

2.7

+/

1.98(+)

2.32(+)

2.5(+)

5.1

6

97.8

7.1

13.2

6.0

3.84(+)

4.81

6.5

11.6

7

108.5

6.8

13.4

5.9

3.70(+)

4.44

6.2

11.6

8

51.9

2.9

4.3()

2.2

+/

4.9(+)

2.83(+)

2.8

5.1

9

45.8

2.8

3.8()

2.4

+/

1.14(+)

2.30(+)

1.3(+)

5.1

10

6.1(+)

0.3()

0.6()

0.2(+)

0.71(+)

0.55(+)

2.1()

2.1()

   *     G6PDU/g Hb, determined at Clin. Biochem. Res. Lab, VGH-Taipei

   **   The positive result assigned by the participants are indicated by red color in the table.

   

篩檢試劑組套

新生兒篩檢中心

ASTORIA  A1
 PE (ND-1000)  A2, B1, C1, D1
 Roche  C2
 Sigma Diagnostic 345B  A3
 Gamma (G6PD-2000)  C4
 R & D Diagnostics (OSMMR2000-D)  C5
 Laboratory prepared  B2, C3

Preventive Medicine Foundation
Address : P.O. Box 624 Taipei Xinwei, Taiwan, 10699
TEL : +886-2-2703-6080 ; Fax : +886-2-2703-6070
email :

updated : 20 Dec, 2004

[Home]


HOME